Cargando…

In vitro and in vivo evaluation of self-assembled chitosan nanoparticles selectively overcoming hepatocellular carcinoma via asialoglycoprotein receptor

Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related mortality worldwide. Nowadays, liver-targeting drug delivery system has been proven as a promising strategy for overcoming HCC. Asialoglycoprotein receptor (ASGPR) is an ideal receptor for liver targeting, which is mainly ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Rensong, Fang, Linlin, Lv, Xia, Fang, Jiani, Wang, Yuting, Chen, Dapeng, Wang, Liang, Chen, Jun, Qi, Yan, Tang, Zeyao, Zhang, Jianbin, Tian, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491732/ https://www.ncbi.nlm.nih.gov/pubmed/34595970 http://dx.doi.org/10.1080/10717544.2021.1983077

Ejemplares similares

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
por: Pranatharthiharan, Sandhya, et al.
Publicado: (2017)

Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma
por: Nair, Anroop B., et al.
Publicado: (2019)

Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
por: Xue, Wan-Jiang, et al.
Publicado: (2016)

Asialoglycoprotein Receptor-Targeted Superparamagnetic Perfluorooctylbromide Nanoparticles
por: Li, Yang, et al.
Publicado: (2021)

Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma
por: Yousef, Shaimaa, et al.
Publicado: (2018)

The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells
por: Trerè, D, et al.
Publicado: (1999)

Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
por: Quan, Guilan, et al.
Publicado: (2015)

Erratum to: Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
por: Quan, Guilan, et al.
Publicado: (2015)

Detection of Circulating Tumor Cells in Hepatocellular Carcinoma Using Antibodies against Asialoglycoprotein Receptor, Carbamoyl Phosphate Synthetase 1 and Pan-Cytokeratin
por: Li, Jun, et al.
Publicado: (2014)

An in vivo Method for Determination of Endosomal Distribution of Both Ligand and Asialoglycoprotein Receptor in Rat Liver
por: Dalton, Shana R, et al.
Publicado: (2004)

Monensin inhibits intracellular dissociation of asialoglycoproteins from their receptor
Publicado: (1983)

Distribution of an asialoglycoprotein receptor on rat hepatocyte cell surface
Publicado: (1982)

Immunocytochemical localization of the receptor for asialoglycoprotein in rat liver cells
Publicado: (1982)

LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
por: Ahn, Green, et al.
Publicado: (2021)

Self-assembled ternary hybrid nanodrugs for overcoming tumor resistance and metastasis
por: Cheng, Xu, et al.
Publicado: (2021)

Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells
Publicado: (1984)

Ligand- and weak base-induced redistribution of asialoglycoprotein receptors in hepatoma cells
Publicado: (1987)

Three-Dimensional Models of the Oligomeric Human Asialoglycoprotein Receptor (ASGP-R)
por: Massarelli, Ilaria, et al.
Publicado: (2010)

Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity
por: Roggenbuck, Dirk, et al.
Publicado: (2012)

Multi-applications of carbon dots and polydopamine-coated carbon dots for Fe(3+) detection, bioimaging, dopamine assay and photothermal therapy
por: Chen, Jun, et al.
Publicado: (2023)

Docetaxel-Loaded Chitosan-Cholesterol Conjugate-Based Self-Assembled Nanoparticles for Overcoming Multidrug Resistance in Cancer Cells
por: Mu, Chao-Feng, et al.
Publicado: (2020)

Galactosylated Chitosan Oligosaccharide Nanoparticles for Hepatocellular Carcinoma Cell-Targeted Delivery of Adenosine Triphosphate
por: Zhu, Xiu Liang, et al.
Publicado: (2013)

Raloxifene/SBE-β-CD Inclusion Complexes Formulated into Nanoparticles with Chitosan to Overcome the Absorption Barrier for Bioavailability Enhancement
por: Wang, Zaihua, et al.
Publicado: (2018)

A New Splice Variant of the Major Subunit of Human Asialoglycoprotein Receptor Encodes a Secreted Form in Hepatocytes
por: Liu, Jia, et al.
Publicado: (2010)

Two pathways for the degradation of the H2 subunit of the asialoglycoprotein receptor in the endoplasmic reticulum
Publicado: (1993)

A Drug Delivery Strategy: Binding Enkephalin to Asialoglycoprotein Receptor by Enzymatic Galactosylation
por: Christie, Michelle P., et al.
Publicado: (2014)

Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo
por: Wu, Yan, et al.
Publicado: (2012)

A Novel Copolymer-Based Functional SPECT/MR Imaging Agent for Asialoglycoprotein Receptor Targeting
por: Zhang, Pu, et al.
Publicado: (2016)

Arsenite-loaded nanoparticles inhibit PARP-1 to overcome multidrug resistance in hepatocellular carcinoma cells
por: Liu, Hanyu, et al.
Publicado: (2016)

Self-Assembly Nanoparticles for Overcoming Multidrug Resistance and Imaging-Guided Chemo-Photothermal Synergistic Cancer Therapy
por: Gao, Haiyan, et al.
Publicado: (2020)

Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line
por: Guhagarkar, Swati A., et al.
Publicado: (2011)

Triantennary GalNAc-Functionalized Multi-Responsive Mesoporous Silica Nanoparticles for Drug Delivery Targeted at Asialoglycoprotein Receptor
por: Cordeiro, Rosemeyre, et al.
Publicado: (2022)

Receptor-mediated endocytosis of asialoglycoproteins by rat hepatocytes: receptor-positive and receptor-negative endosomes
Publicado: (1986)

Receptor-mediated endocytosis of asialoglycoproteins by rat liver hepatocytes: biochemical characterization of the endosomal compartments
Publicado: (1985)

Effect of lysosomotropic amines on the secretory pathway and on the recycling of the asialoglycoprotein receptor in human hepatoma cells
Publicado: (1985)

Rapid acidification of endocytic vesicles containing asialoglycoprotein in cells of a human hepatoma line
Publicado: (1983)

Rat hepatocytes bind to synthetic galactoside surfaces via a patch of asialoglycoprotein receptors
Publicado: (1980)

Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor
por: Schmidt, Karsten, et al.
Publicado: (2017)

Impact of Asialoglycoprotein Receptor and Mannose Receptor Deficiency on Murine Plasma N-glycome Profiles
por: Svecla, M., et al.
Publicado: (2023)

Inhibiting USP8 overcomes hepatocellular carcinoma resistance via suppressing receptor tyrosine kinases
por: Zhu, Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lfvtflugnqnr6325ocs2omspp7